Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PFE compared with BMY: revenue, margins and what each company keeps, and the suppliers and customers both name
PFE
Pfizer Inc
Change
Mkt cap
Revenue
Revenue
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
PFE
Pfizer Inc
vs
BMY
Bristol Myers Squibb Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
PFE
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±3.3%
▲
+1.52%
×0.45
Q1 FY26
±3.5%
▲
+0.57%
×0.17
Feb 3 '26
±3.2%
▼
−3.34%
×1.03
Q3 FY25
±4.2%
▼
−1.46%
×0.36
BMY
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.6%
▲
+1.35%
×0.39
Q2 FY26
±3.7%
▲
+2.79%
×0.76
Q1 FY26
±4.1%
▲
+5.21%
×1.27
Feb 5 '26
±3.8%
▲
+3.30%
×0.87
= implied
PFE realized, solid
BMY realized, hatched
One scale, both sides: full bar = 6%
× = |realized| ÷ implied
Source: market data
PFE
Pfizer Inc
Change
30.50
· pre 30.44
Mkt cap
$174.0B
Revenue
$15.0B
Q2 FY26
Revenue
$62.6B
FY25
BMY
Bristol Myers Squibb Co
Change
62.52
· pre 62.43
Pre-market
Sep 2 '83
Mkt cap
$127.7B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
vs
Compare
Pre-market
Sep 2 '83
PFE
Pfizer Inc
vs
BMY
Bristol Myers Squibb Co
30.50
pre 30.44
Price
62.52
pre 62.43
$174.0B
Mkt cap
$127.7B
Q2 FY26
$15.0B
Revenue
$13.1B
Q3 FY26
FY25
$62.6B
Revenue
$48.2B
FY25
Change
Change
PFE
30.50
vs
BMY
62.52
Pre-market
Sep 2 '83